v3.26.1
REVENUE
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition
Products
Substantially all of DuPont's revenue is derived from product sales. Product sales consist of sales of DuPont's products to supply manufacturers and distributors. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.

Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.

The net trade revenue table below reflects the Q4 2025 Segment Realignment structure.
Net Trade Revenue by Segment and Business or Major Product LineThree Months Ended March 31,
In millions20262025
Healthcare Technologies$467 $419 
Water Technologies339 344 
Healthcare & Water Technologies$806 $763 
Industrial Technologies$504 $474 
Building Technologies371 375 
Diversified Industrials$875 $849 
Total$1,681 $1,612 

Net Trade Revenue by Geographic RegionThree Months Ended March 31,
In millions20262025
United States$769 $746 
EMEA 1
385 353 
Asia Pacific399 376 
Other 2
128 137 
Total$1,681 $1,612 
1.Europe, Middle East and Africa.
2.Other includes Latin America and Canada.

Contract Balances
From time to time, the Company enters into arrangements in which it receives payments from customers based upon contractual billing schedules. The Company records accounts receivables when the right to consideration becomes unconditional. Contract liabilities primarily reflect deferred revenue from advance payment for products that the Company has received from customers. The Company classifies deferred revenue as current or noncurrent based on the timing of when the Company expects to recognize revenue.

The Company’s contract balances consisted primarily of trade accounts receivable of $953 million at March 31, 2026 and $920 million at December 31, 2025 included in “Accounts and notes receivable – net” in the interim Condensed Consolidated Balance Sheets. Deferred revenue, current and noncurrent, were immaterial at March 31, 2026 and December 31, 2025.
Revenue recognized for the three months ended March 31, 2026 and 2025 from amounts included in contract liabilities at the beginning of the period was immaterial.